Pharmafile Logo

Infographic: North Asia

August 25, 2015 | Pharma, north asia 

An overview of the five most-commonly researched, largest pharma markets in North Asia.

North Asia’s largest markets; China, Hong Kong, Japan, South Korea and Taiwan, are home to more than 1.6 billion people and is a key global growth region. With pharmaceutical sales of more than $215bn, it is an attractive region for pharma, however one in which each market differs in terms of opportunities – and challenges.

Download our infographic at http://www.researchpartnership.com/news/2015/05/infographic-north-asia/ 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webcast: Leveraging the ASEAN opportunities

Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

Webcast: Biosimilars: Friend or Foe to Healthcare?

Understanding the opportunities for biosimilars and the threats to innovator biologics

Webinar: Understanding the patient journey in China

The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers...

Webinar: Capturing “in-the-moment” patient and physician insights

Utilising the benefits of mobile technology

Webinar: Observational Research

Presenting a window on the world of your customer

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates